Potential interactions between triazole antifungal agents and lorlatinib based on ultra-performance liquid chromatography-tandem mass spectrometry in rat plasma
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgad105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Zhongjiang Ye und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000 Zhejiang, China. Hauptthemen laut MEDLINE: Antifungal Agents, Itraconazole, Aminopyridines, Lactams. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Medical Health Science and Technology Project of Zhejiang Provincial Health Commission, Project of Wenzhou Science and Technology Bureau.
Abstract (Originalsprache)
Aim
Our study is to investigate the effects of triazole antifungal drugs on the pharmacokinetics of lorlatinib in rats.
Methods
The samples were precipitated with methanol. Chromatographic separation was performed on a ultra-performance liquid chromatography (UPLC) system using a BEH C18 column. The mobile phase consisted of 0.1% formic acid water and methanol. Lorlatinib and crizotinib (internal standard) were detected in multiple reaction monitoring mode. The fragment ions were 407.3–228.07 for lorlatinib and m/z 450.3–260.0 for crizotinib. Lorlatinib and different triazole antifungal drugs were given to Sprague Dawley rats by gavage, and blood was collected from the tail vein at a certain time point. The validated UPLC–MS/MS method was applied to a drug interaction study of ketoconazole, voriconazole, itraconazole, and posaconazole with lorlatinib in rats.
Results
Ketoconazole and voriconazole significantly inhibited lorlatinib metabolism. When administration with ketoconazole and voriconazole, the area under the curve from time zero to infinity of lorlatinib increased by 49.0% and 104.3%, respectively; the clearance decreased by 40.0% and 40.0%, respectively. While itraconazole and posaconazole did not affect lorlatinib pharmacokinetics.
Conclusion
The UPLC-MS/MS-based assay is helpful to further understand the pharmacokinetics of lorlatinib in rats, and confirmed the findings that the combination of lorlatinib with CYP3A inhibitors should be avoided as predicted by our pre-clinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000 Zhejiang, China.
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325000 Zhejiang, China.
- Clinical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000 Zhejiang, China.
- Key Laboratory of Intelligent Treatment and Life Support for Critical Diseases of Zhejiang Province, Wenzhou, 325000 Zhejiang, China.
ORCID-Profile: Chenxiang Wang
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Medical Health Science and Technology Project of Zhejiang Provincial Health Commission
- Project of Wenzhou Science and Technology Bureau
Zitieren
APA
Ye, Z., Wang, C., Li, R., Chen, C., Yang, J., Chen, Y., Fu, J., Zhou, T., Jin, M., Huang, A., Zhang, X., & Zhou, Z. (2024). Potential interactions between triazole antifungal agents and lorlatinib based on ultra-performance liquid chromatography-tandem mass spectrometry in rat plasma. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad105
Vancouver
Ye Z, Wang C, Li R, Chen C, Yang J, Chen Y, et al. Potential interactions between triazole antifungal agents and lorlatinib based on ultra-performance liquid chromatography-tandem mass spectrometry in rat plasma. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgad105
BibTeX
@article{Ye2024,
author = {Ye, Zhongjiang and Wang, Chenxiang and Li, Rongqi and Chen, Chuang and Yang, Jianhui and Chen, Yizhang and Fu, Jing and Zhou, Tao and Jin, Mi and Huang, Aifang and Zhang, Xiuhua and Zhou, Ziye},
title = {Potential interactions between triazole antifungal agents and lorlatinib based on ultra-performance liquid chromatography-tandem mass spectrometry in rat plasma},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgad105}
}
EUVIMED